Diltiazem Hcl ER 180mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely.
Take your medication as directed by your doctor, swallowing the tablets whole without chewing, breaking, or crushing them.
Establish a routine by taking your medication at the same time every day.
Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start feeling well.
Storing and Disposing of Your Medication
To maintain the effectiveness and safety of your medication:
Store it at room temperature, protected from light and moisture. Avoid storing it in a bathroom.
Keep your medication in a safe and secure location, out of the reach of children and pets.
Dispose of unused or expired medication responsibly. Do not flush it down the toilet or pour it down the drain unless instructed to do so by your pharmacist or healthcare provider. Check with your pharmacist for guidance on the best disposal method, and consider participating in local drug take-back programs.
What to Do If You Miss a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Avoid taking two doses at the same time or taking extra doses to make up for a missed one.
Lifestyle & Tips
- Take the medication exactly as prescribed, usually once daily. Do not crush, chew, or divide extended-release tablets.
- Do not stop taking the medication suddenly without consulting your doctor, as this can worsen your condition.
- Avoid grapefruit and grapefruit juice while taking this medication, as it can increase the drug's levels in your body.
- Maintain a healthy lifestyle, including a balanced diet (low in sodium and saturated fats), regular exercise, and stress management, to support blood pressure control.
- Limit alcohol consumption, as it can also lower blood pressure and increase dizziness.
- Monitor your blood pressure and heart rate regularly at home if advised by your doctor.
Available Forms & Alternatives
Available Strengths:
- Diltiazem SR 120mg Capsules (12 Hr)
- Diltiazem ER 90mg Capsules (12 Hr)
- Diltiazem ER 60mg Capsules (12 Hr)
- Diltiazem XR 120mg Capsules (24 Hr)
- Diltiazem 30mg Tablets
- Diltiazem 120mg Tablets
- Diltiazem 90mg Tablets
- Diltiazem XR 240mg Capsules (24 Hr)
- Diltiazem 60mg Tablets
- Diltiazem ER 180mg Caps (xr-24h)
- Diltiazem ER 360mg Capsules (24 Hr)
- Diltiazem ER 360mg (24 Hr/cd) Caps
- Diltiazem ER 420mg Tablets
- Diltiazem ER 180mg Capsules (24 Hr)
- Diltiazem ER 240mg Capsules (24 Hr)
- Diltiazem ER 420mg Capsules (24 Hr)
- Diltiazem ER 240mg Tabs (la 24hr)
- Diltiazem ER 120mg Capsules (24 Hr)
- Diltiazem ER 300mg Capsules (24 Hr)
- Diltiazem Hcl ER 180mg Tablets
- Diltiazem ER 300mg Capsules (24 Hr)
- Diltiazem ER 360mg Tablets (la 24h)
- Diltiazem ER 180mg Capsules
- Diltiazem ER 360mg Capsules (24 Hr)
- Diltiazem Hcl ER 180mg Tablets
- Diltiazem ER 360mg Tablets (la 24h)
- Diltiazem ER 300mg Tablets (la 24h)
- Diltiazem CD 240mg Capsules (24 Hr)
- Diltiazem CD 300mg Capsules (24 Hr)
- Diltiazem CD 180mg Capsules (24 Hr)
- Diltiazem ER 360mg (24 Hr/cd) Caps
- Diltiazem CD 120mg Capsules (24 Hr)
- Diltiazem CD 240mg Capsules (24 Hr)
- Diltiazem CD 180mg Capsules (24 Hr)
- Diltiazem CD 120mg Capsules (24 Hr)
- Diltiazem ER 360mg (24 Hr/cd) Caps
- Diltiazem CD 300mg Capsules (24 Hr)
- Diltiazem CD 180mg Capsules (24hr)
- Diltiazem ER 120mg Tablets (la 24h)
- Diltiazem ER 120mg Tablets (la 24h)
- Diltiazem 5mg/ml Inj, 5ml
- Diltiazem 125mg/25ml Inj, 25ml
- Diltiazem 50mg/10ml Inj, 10ml
- Diltiazem 100mg Inj, 1 Vial
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you experience any of the following symptoms, seek medical attention right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of liver problems, including:
+ Dark urine
+ Tiredness
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Severe dizziness or fainting
Slow heartbeat
Abnormal heartbeat that is new or worsening
Worsening heart failure, characterized by:
+ Shortness of breath
+ Significant weight gain
+ Swelling in the arms or legs (if you have a history of heart failure, discuss this with your doctor)
Severe skin reactions, including:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other severe skin reactions, which may be life-threatening
+ Signs of severe skin reactions include:
- Red, swollen, blistered, or peeling skin
- Skin irritation with or without fever
- Red or irritated eyes
- Sores in the mouth, throat, nose, or eyes
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people experience no side effects or only mild ones. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:
Headache
* Feeling dizzy, tired, or weak
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe dizziness or lightheadedness, especially when standing up.
- Fainting spells.
- Unusual swelling in your ankles, feet, or hands.
- Difficulty breathing or shortness of breath, especially with exertion or lying down.
- Very slow heart rate (e.g., less than 50 beats per minute) or irregular heartbeat.
- New or worsening chest pain.
- Signs of liver problems: yellowing of skin or eyes (jaundice), dark urine, persistent nausea/vomiting, severe stomach pain.
Before Using This Medicine
It is essential to inform your doctor about the following conditions to ensure safe use of this medication:
Any allergies you have, including allergies to this drug, its components, or other substances. Be sure to describe the allergic reaction and its symptoms.
Certain types of abnormal heart rhythms, as this medication may not be suitable for use in these conditions. If you are unsure, consult your doctor or pharmacist for guidance.
Presence of any of the following health issues: fluid accumulation in the lungs, low blood pressure, or a recent heart attack.
Current use of ivabradine or rifampin, as these medications may interact with this drug.
This list is not exhaustive, and it is crucial to disclose all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any existing health problems. Your doctor and pharmacist need this information to assess potential interactions and ensure safe use of this medication. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
When starting this medication, avoid driving and other activities that require alertness until you understand how it affects you. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying position, and be cautious when climbing stairs.
As directed by your doctor, regularly monitor your blood pressure and heart rate. You may need to undergo an electrocardiogram (ECG) before initiating this medication and during treatment. Discuss this with your doctor.
If you have high blood pressure and are taking this medication, consult your doctor before using over-the-counter (OTC) products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, and certain natural products or aids.
If you consume grapefruit juice or eat grapefruit regularly, discuss this with your doctor. Additionally, talk to your doctor before consuming alcohol while taking this medication.
If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.
It is crucial to inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. You and your doctor will need to discuss the potential benefits and risks of this medication to both you and your baby.
Overdose Information
Overdose Symptoms:
- Severe bradycardia (very slow heart rate)
- Profound hypotension (very low blood pressure)
- Heart block (impaired electrical conduction in the heart)
- Asystole (cardiac arrest)
- Cardiogenic shock
- Congestive heart failure
- Dizziness, confusion, stupor, coma
What to Do:
Seek immediate medical attention. Call 911 or your local emergency number. For poison control, call 1-800-222-1222. Treatment may involve gastric lavage, activated charcoal, IV fluids, atropine, calcium gluconate, vasopressors, and/or cardiac pacing depending on the severity and symptoms.
Drug Interactions
Contraindicated Interactions
- Ivabradine (risk of severe bradycardia)
- Dantrolene (IV) (risk of hyperkalemia and myocardial depression)
Major Interactions
- Beta-blockers (e.g., metoprolol, propranolol): Increased risk of bradycardia, AV block, and heart failure.
- Digoxin: Increased digoxin serum concentrations (monitor levels).
- Statins (e.g., simvastatin, lovastatin, atorvastatin): Increased statin exposure due to CYP3A4 inhibition (reduce statin dose).
- Amiodarone: Increased risk of bradycardia, sinus arrest, AV block.
- Fentanyl: Increased fentanyl exposure (CYP3A4 inhibition).
- Midazolam, Triazolam: Increased benzodiazepine exposure (CYP3A4 inhibition).
- Cyclosporine, Tacrolimus, Sirolimus: Increased immunosuppressant levels (CYP3A4 inhibition, monitor levels).
- Quinidine, Procainamide: Increased risk of QT prolongation and arrhythmias.
- Phenytoin, Carbamazepine: Increased levels of these anticonvulsants.
- Rifampin, Phenobarbital: Decreased diltiazem levels (CYP3A4 induction).
- Cimetidine: Increased diltiazem levels (CYP3A4 inhibition).
Moderate Interactions
- Alpha-blockers (e.g., prazosin, doxazosin): Additive hypotensive effects.
- Nitrates: Additive hypotensive effects.
- Clonidine: Additive bradycardia and AV block.
- Grapefruit juice: May increase diltiazem levels (CYP3A4 inhibition).
Minor Interactions
- NSAIDs: May reduce the antihypertensive effect of diltiazem.
Monitoring
Baseline Monitoring
Rationale: To establish baseline and guide initial dosing for hypertension.
Timing: Prior to initiation
Rationale: To establish baseline and assess for bradycardia, especially in patients with pre-existing bradycardia or on other rate-lowering drugs.
Timing: Prior to initiation
Rationale: To assess for pre-existing conduction abnormalities (e.g., AV block) and establish baseline PR interval.
Timing: Prior to initiation
Rationale: Diltiazem is extensively metabolized by the liver; to assess baseline hepatic function.
Timing: Prior to initiation
Rationale: To assess baseline renal function, although dose adjustment is less critical than for hepatic impairment.
Timing: Prior to initiation
Routine Monitoring
Frequency: Regularly, especially during dose titration and periodically thereafter.
Target: <130/80 mmHg (or individualized target)
Action Threshold: Persistent hypotension (e.g., SBP <90 mmHg) or inadequate BP control.
Frequency: Regularly, especially during dose titration and periodically thereafter.
Target: 50-90 bpm (or individualized target)
Action Threshold: Persistent bradycardia (<50 bpm) or symptomatic bradycardia.
Frequency: Periodically, especially with dose increases or concomitant use of other AV nodal blocking agents.
Target: Normal PR interval (<0.20 seconds)
Action Threshold: Significant PR prolongation or development of higher-degree AV block.
Frequency: Regularly
Target: Absence of new or worsening symptoms
Action Threshold: Development of dyspnea, peripheral edema, weight gain, or other signs of heart failure.
Frequency: Periodically, especially if symptoms of hepatic dysfunction develop.
Target: Within normal limits
Action Threshold: Significant elevation of liver enzymes (e.g., >3x ULN).
Symptom Monitoring
- Dizziness
- Lightheadedness
- Fatigue
- Peripheral edema (swelling of ankles/feet)
- Shortness of breath
- Chest pain (angina, monitor for improvement or worsening)
- Palpitations
- Headache
- Nausea
Special Patient Groups
Pregnancy
Diltiazem is classified as Pregnancy Category C. Studies in animals have shown adverse effects on the fetus, but there are no adequate and well-controlled studies in pregnant women. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Trimester-Specific Risks:
Lactation
Diltiazem is excreted in human breast milk. The American Academy of Pediatrics considers diltiazem to be compatible with breastfeeding, but caution is advised. Monitor the infant for potential adverse effects such as bradycardia, hypotension, or sedation.
Pediatric Use
Safety and efficacy have not been established in pediatric patients for hypertension or angina. Use is generally not recommended outside of specific, limited indications (e.g., certain arrhythmias) where benefits outweigh risks, and under specialist supervision.
Geriatric Use
Elderly patients may have increased sensitivity to the effects of diltiazem due to age-related decreases in hepatic and renal function, and potential for polypharmacy. Start with lower doses and titrate slowly, monitoring closely for adverse effects such as bradycardia, hypotension, and constipation.
Clinical Information
Clinical Pearls
- Diltiazem ER formulations are not interchangeable; different brands may have different pharmacokinetic profiles and should not be substituted without physician approval.
- Instruct patients not to crush, chew, or divide extended-release tablets, as this can lead to rapid release of the drug and potential overdose.
- Monitor for signs of heart failure, especially in patients with pre-existing left ventricular dysfunction.
- Be aware of significant drug interactions, particularly with CYP3A4 substrates/inhibitors and other agents that affect heart rate or AV conduction.
- Patients may notice a 'ghost tablet' in their stool, which is the inert matrix of the extended-release tablet and is normal.
Alternative Therapies
- Other Calcium Channel Blockers (e.g., Amlodipine, Verapamil, Felodipine)
- Beta-blockers (e.g., Metoprolol, Atenolol, Carvedilol)
- ACE Inhibitors (e.g., Lisinopril, Enalapril)
- Angiotensin Receptor Blockers (ARBs) (e.g., Valsartan, Losartan)
- Diuretics (e.g., Hydrochlorothiazide, Furosemide)
- Nitrates (for angina, e.g., Isosorbide mononitrate)